Of note, although ACLY is upregulated in HCC and reduced expression correlates with improved survival, previous studies have focused predominantly on viral-related or toxin-related HCC1,21–25, leaving its role in MASH-HCC unexplored. Here, ACLY is linked to hepatocellular carcinoma.